Supernus Pharmaceuticals, Inc.

MACQUARIE GROUP LTD SUPN

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/13/2025

Shares

2,531,537

Value ($000)

120,982

Weight

0.1%

2019 Q4 - 2025 Q3 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/13/2025	120,982	0.1%	2,531,537	9/30/2025
2025 Q1	5/15/2025	88,414	0.1%	2,699,667	3/31/2025
2024 Q4	2/14/2025	95,061	0.1%	2,628,907	12/31/2024
2024 Q3	11/14/2024	82,063	0.1%	2,631,897	9/30/2024
2024 Q2	8/9/2024	71,685	0.1%	2,679,796	6/30/2024
2024 Q1	5/14/2024	91,039	0.1%	2,668,996	3/31/2024
2023 Q4	2/14/2024	79,230	0.1%	2,737,716	12/31/2023
2023 Q3	11/14/2023	75,841	0.1%	2,750,856	9/30/2023
2023 Q2	10/27/2023	75,254	0.1%	2,503,458	6/30/2023
2023 Q1	6/1/2023	89,636	0.1%	2,474,069	3/31/2023
2022 Q4	2/21/2023	86,340	0.1%	2,420,534	12/31/2022
2022 Q3	11/14/2022	80,247	0.1%	2,370,120	9/30/2022
2022 Q2	8/17/2022	67,595	0.1%	2,337,304	6/30/2022
2022 Q1	5/16/2022	74,981	0.1%	2,319,950	3/31/2022
2021 Q4	2/11/2022	63,319	0.1%	2,171,428	12/31/2021
2021 Q3	11/12/2021	56,995	0.0%	2,137,071	9/30/2021
2021 Q2	8/13/2021	65,765	0.1%	2,135,923	6/30/2021
2021 Q1	5/14/2021	54,552	0.1%	2,083,718	3/31/2021
2020 Q4	2/16/2021	55,633	0.1%	2,211,160	12/31/2020
2020 Q3	11/13/2020	42,743	0.1%	2,050,999	9/30/2020
2020 Q2	8/11/2020	44,459	0.1%	1,871,954	6/30/2020
2020 Q1	5/15/2020	31,092	0.1%	1,728,264	3/31/2020
2019 Q4	3/18/2020	35,717	0.1%	1,505,820	12/31/2019